ACM
CVS icon

Anfield Capital Management’s CVS Health CVS Stock Holding History

Anfield Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.24K Sell
73
-95
-57% -$7.32K ﹤0.01% 504
2025
Q4 		$13.3K Buy
168
+95
+130% +$7.49K ﹤0.01% 307
2025
Q3 		$5.5K Sell
73
-18
-20% -$1.23K ﹤0.01% 398
2025
Q2 		$6.28K Buy
91
+18
+25% +$1.18K ﹤0.01% 350
2025
Q1 		$4.95K Hold
73
– – ﹤0.01% 326
2024
Q4 		$3.28K Hold
73
– – ﹤0.01% 349
2024
Q3 		$4.59K Hold
73
– – ﹤0.01% 327
2024
Q2 		$4.31K Buy
+73
New +$4.57K ﹤0.01% 276
2020
Q1 		– Sell
-371
Closed -$26K – 163
2019
Q4 		$26K Buy
+371
New +$26.1K 0.01% 248

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Anfield Capital Management's CVS Position: Q1 2026 in Review

Anfield Capital Management reduced its CVS Health (CVS) stake by 57% in Q1 2026, selling an estimated $7.32K and leaving 73 shares worth $5.24K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Anfield Capital Management first reported a position in CVS in Q4 2019 and has held it in 9 quarters since. The position peaked at $26K in Q4 2019. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Anfield Capital Management held 73 shares of CVS Health worth $5.24K as of Q1 2026.
  • Anfield Capital Management sold 95 CVS Health shares in Q1 2026, an estimated $7.32K.
  • CVS Health made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #504 holding.
  • Anfield Capital Management first reported a position in CVS Health in Q4 2019 and has held it in 9 quarters since.
  • Anfield Capital Management's CVS Health position peaked at $26K in Q4 2019.
  • 1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.